Literature DB >> 7957509

Adverse drug reactions: physicians' opinions versus a causality assessment method.

G Miremont1, F Haramburu, B Bégaud, J C Péré, J Dangoumau.   

Abstract

Since spontaneous reporting of adverse drug reactions depends on the physician's opinion of the relationship between the drug and the adverse event, we compared physicians' opinions with the scores obtained by the causality assessment method used in France. During a 2 month period, all physicians who reported adverse drug reactions (ADRs) to our pharmacovigilance centre expressed their opinions on the causal link by means of visual analogue scales. ADR reports were then assessed with the French causality assessment method by a clinical pharmacologist who was blind to physicians' opinions. The assessment by both physicians and the standardized method was performed for 75 ADR cases involving 120 drugs. Physicians used a wide range of assessments, with a preponderance of extreme scores, resulting in a U-shaped distribution, while the standardized method gave generally low scores. Scores given by physicians were very high (causality considered very likely or likely) in 60% of cases and very low (causality considered unlikely or dubious/possible) in 32% of cases. Scores obtained using the causality assessment method were low (causality dubious/possible) in 89% of cases and causality considered likely in only 11 cases, essentially in cases with positive rechallenge. Complete agreement occurred in only 6% of cases. Adding complete agreement and minor discrepancies raised the percentage to 49%.

Mesh:

Year:  1994        PMID: 7957509     DOI: 10.1007/BF00194392

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  8 in total

1.  Comparison of 500 spontaneous and 500 published reports of adverse drug reactions.

Authors:  F Haramburu; B Bégaud; J C Péré
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Adverse drug reactions-a matter of opinion.

Authors:  F E Karch; C L Smith; B Kerzner; J M Mazzullo; M Weintraub; L Lasagna
Journal:  Clin Pharmacol Ther       Date:  1976-05       Impact factor: 6.875

3.  Consistency of assessment of adverse drug reactions in psychiatric hospitals: a comparison of an algorithmic and an empirical approach.

Authors:  L G Schmidt; P Dirschedl; R Grohmann; J Scherer; O Wunderlich; B Müller-Oerlinghausen
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

4.  Judgments of trained observers on adverse drug reactions.

Authors:  S Blanc; P Leuenberger; J P Berger; E M Brooke; J L Schelling
Journal:  Clin Pharmacol Ther       Date:  1979-05       Impact factor: 6.875

Review 5.  The diagnosis of adverse medical events associated with drug treatment.

Authors:  M D Stephens
Journal:  Adverse Drug React Acute Poisoning Rev       Date:  1987

6.  The ambiguity of adverse drug reactions.

Authors:  J Koch-Weser; E M Sellers; R Zacest
Journal:  Eur J Clin Pharmacol       Date:  1977-01-03       Impact factor: 2.953

7.  Reasons for disagreement in the standardized assessment of suspected adverse drug reactions.

Authors:  T A Hutchinson; K M Flegel; H HoPingKong; W S Bloom; M S Kramer; E G Trummer
Journal:  Clin Pharmacol Ther       Date:  1983-10       Impact factor: 6.875

8.  [Systematic follow up of inquiries about adverse drug reactions: a 9 month experience].

Authors:  B Begaud; F Haramburu; J C Père; B Lorson; H Albin; J Dangoumau
Journal:  Therapie       Date:  1982 Jul-Aug       Impact factor: 2.070

  8 in total
  15 in total

Review 1.  Manufacturer's drug interaction and postmarketing adverse event data: what are appropriate uses?

Authors:  W K Kraft; S A Waldman
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  Comparison of three methods (consensual expert judgement, algorithmic and probabilistic approaches) of causality assessment of adverse drug reactions: an assessment using reports made to a French pharmacovigilance centre.

Authors:  Hélène Théophile; Yannick Arimone; Ghada Miremont-Salamé; Nicholas Moore; Annie Fourrier-Réglat; Françoise Haramburu; Bernard Bégaud
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

3.  Agreement of expert judgment in causality assessment of adverse drug reactions.

Authors:  Yannick Arimone; Bernard Bégaud; Ghada Miremont-Salamé; Annie Fourrier-Réglat; Nicholas Moore; Mathieu Molimard; Françoise Haramburu
Journal:  Eur J Clin Pharmacol       Date:  2005-04-13       Impact factor: 2.953

4.  Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001).

Authors:  Frantz Thiessard; Emmanuel Roux; Ghada Miremont-Salamé; Annie Fourrier-Réglat; Françoise Haramburu; Pascale Tubert-Bitter; Bernard Bégaud
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 5.  The art and science of risk management: a US research-based industry perspective.

Authors:  Janice K Bush; Wanju S Dai; Gretchen S Dieck; Linda S Hostelley; Thomas Hassall
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 6.  Methods for causality assessment of adverse drug reactions: a systematic review.

Authors:  Taofikat B Agbabiaka; Jelena Savović; Edzard Ernst
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

7.  Inter-expert agreement of seven criteria in causality assessment of adverse drug reactions.

Authors:  Yannick Arimone; Ghada Miremont-Salamé; Françoise Haramburu; Mathieu Molimard; Nicholas Moore; Annie Fourrier-Réglat; Bernard Bégaud
Journal:  Br J Clin Pharmacol       Date:  2007-08-15       Impact factor: 4.335

Review 8.  [Detection and evaluation of adverse drug reactions].

Authors:  P A Thürmann; K Schmitt
Journal:  Med Klin (Munich)       Date:  1998-11-15

Review 9.  Does orlistat cause acute kidney injury?

Authors:  Michael M Beyea; Amit X Garg; Matthew A Weir
Journal:  Ther Adv Drug Saf       Date:  2012-04

10.  Is Duhuo Jisheng Tang containing Xixin safe? A four-week safety study.

Authors:  Shu-Ching Hsieh; Jung-Nien Lai; Pau-Chung Chen; Chao-Chung Chen; Huey-Jen Chen; Jung-Der Wang
Journal:  Chin Med       Date:  2010-02-11       Impact factor: 5.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.